top of page

healthcare professional resources

THE PHARMACY ACCESS TO RESOURCES AND MEDICATION FOR OPIOID USE DISORDER (PhARM-OUD) GUIDELINE

PhARM-OUD Guideline

Addressing Issues at the Pharmacy with Buprenorphine Prescriptions Addressing Issues at the Pharmacy with Buprenorphine Prescriptions A Toolkit for Clinicians A Toolkit for Clinicians Dispensing Buprenorphine at the Pharmacy Although buprenorphine is an FDA-approved medication to treat opioid use disorder (OUD) that was dispensed almost 16 million times in 2023, practitioners prescribing it still encounter pharmacists with questions or concerns about the prescription. While pharmacists are expected to fill prescriptions issued for a legitimate medical purpose to a patient that is expected to benefit from the treatment, they also have a corresponding responsibility that gives them autonomy to decline to fill prescriptions in cases where the pharmacist is unable to resolve their concerns about the validity of the prescription. In essence, a pharmacist is not legally required to dispense buprenorphine simply because it was prescribed.-

ASAM Clinician Toolkit

Resources to Share with Patients

Pharmacy bill of rights know your rights buprenorphine, suboxone, and subutex, at the pharmacy. oniell institute center on addiction and public policy. faces and voices of recovery. pharmacy patients bill of rights

Pharmacy Patient's Bill of Rights

A Pharmacy Guide for Buprenorphine Patients: Suboxone, Subutex, and Zubsolv that states Common Problems and What You Can Say. pharmacy guide for buprenorphine patients

Pharmacy Guide for Buprenorphine Patients

Accessing buprenorphine at the pharmacy. a guide for patients suboxone subutex, zubsolv

Accessing Buprenorphine Pamplet

Naloxone Stability Info

stability

billofrights

helpful links

Grayken Center for Addiction Training & Technical Assistance

BRIDGE Methadone Hospital Quick Start

SAMHSA Buprenorphine Quick Start Guides

BRIDGE Buprenorphine Emergency Department Quick Start

Boston Medical Center MAT Quick Start App

ASAM National Practice Guidelines

SAMHSA Medications for Opioid Use Disorder

Cleveland Clinic Journal of Medicine: A Guide for Buprenorphine Initiation

The New England Journal of Medicine: Primary Care and the Opioid-Overdose Crisis

Springer Nature: Harm Reduction Journal

Annals of Family Medicine: Mortality Associated With Time in and Out of Buprenorphine Treatment

National Library of Medicine: Mortality among individuals accessing pharmacological treatment for opioid dependence in California

theBMJ: Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

SAMHSA: Enhancing Motivation for Change in Substance Use Disorder Treatment

bottom of page